Caredx to participate in upcoming conferences

South san francisco, calif., feb. 03, 2022 (globe newswire) -- caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the company will participate in the btig virtual medtech, digital health, life science & diagnostic tools conference and the raymond james 43rd annual institutional investors conference.
CDNA Ratings Summary
CDNA Quant Ranking